individualized glycemic control in type 2 diabetic patients in iran: a multi-center data analysis

Background: clinical guidelines and expert committees have recently suggested that the hemoglobin a1c (hba1c) should be individualized based on various criteria. data regarding the achievement of individualized glycemic targets in type 2 diabetes mellitus (t2dm) patients is scant in iran. we intended to provide information found on real-world outcomes from the perspective of an individualized recommendation.methods: a cross-sectional analysis was conducted in 15 diabetes centers in iran between 2013-2017. two steps cluster sampling selection was used to recruit 1591 patients with t2dm. considering ismail-beigi’s individualized strategy, the study population was categorized into five treatment intensities of hba1c: most intensive (≤6.5%), intensive (6.5–7.0%), less intensive (~7.0%), not intensive (7.0–8.0%), and moderated (~8.0%). the percentage of patients who met their group individualized glycemic targets was estimated as the degree of achievement of each treatment intensity.results: the cumulative incidence rate of early microvascular, advanced microvascular, and macrovascular complications was 53%, 25%, and 34%, respectively. besides, 78% [77.6-79%] of patients did not achieve individualized glycemic targets. conclusion: the outcome showed poor individualized glycemic control and a high incidence of diabetes complications. considering individualized hba1c targets for iranian patients with t2dm is an urgent need.